Pharma International reviews the decision on how to run the anti-products in Nigeria, and if so, how it should be implemented. Includes commercial, ethical and political considerations. Rich data assessment, the case relates to the criticism of pharmaceutical marketing practices in the Third World, and Ciba-Geigy in Servipharm initiative, one answer to this question. "Hide
by N. Craig Smith, John A. Quelch Source: Harvard Business School 16 pages. Publication Date: July 28, 1989. Prod. #: 589108-PDF-ENG
Related Case Solutions & Analyses:
Calculated Risk: Framework for Evaluating Product Development
AOL Time Warner
MARKETING STRATEGIES
Starbucks in Florida
What’s Next for the Chinese Economy?
Mama’s and Papa’s Brand
Ombre, Tie-Dye, Splat Hair: Trends or Fads? “Pull” and “Push” Social Media Strategies at L’Oréal Paris
Eastern Condiments Private Limited (C)
Journey to the East: Natcore Technology in China
From In-house to Joint R&D: The Way forward for Nokia Denmark
